机构:[1]Department of Hematology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, shanghai, China[2]Department of Hematology, Shanghai Tongren Hospital Aflated to Shanghai Jiaotong University, Shanghai, China[3]Shanghai Jiaotong University School of Medicine, Shanghai, China[4]Department of Hematology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China[5]Department of Hematology, Hongqiao International institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Chi
第一作者机构:[1]Department of Hematology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, shanghai, China
推荐引用方式(GB/T 7714):
Lu Yingting,Ying Chunrong,Liu Ligen,et al.Safety and Efficacy of R-PAD Regimen in Patients with Severe Multiple Center Idiopathic Castleman Disease: A Retrospective Case Series[J].BLOOD.2024,144:6888-6888.doi:10.1182/blood-2024-207982.
APA:
Lu, Yingting,Ying, Chunrong,Liu, Ligen,Zhao, Limin,Jiang, Xuewei...&Yang, Li.(2024).Safety and Efficacy of R-PAD Regimen in Patients with Severe Multiple Center Idiopathic Castleman Disease: A Retrospective Case Series.BLOOD,144,
MLA:
Lu, Yingting,et al."Safety and Efficacy of R-PAD Regimen in Patients with Severe Multiple Center Idiopathic Castleman Disease: A Retrospective Case Series".BLOOD 144.(2024):6888-6888